Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Inflammation 1 Frailty 1

Interventions

pembrolizumab 110 Specimen Handling 79 Magnetic Resonance Spectroscopy 70 Carboplatin 67 Cisplatin 66 Biopsy 57 Nivolumab 56 Radiotherapy 50 Cyclophosphamide 50 Paclitaxel 48 durvalumab 38 Radiation 37 Gemcitabine 37 olaparib 32 Rituximab 32 Etoposide 32 Dexamethasone 32 Doxorubicin 30 Docetaxel 30 atezolizumab 28 Lenalidomide 27 Ipilimumab 27 Taxes 26 Pemetrexed 25 Bevacizumab 25 Vincristine 24 Cytarabine 24 Prednisone 23 Platinum 23 Radiotherapy, Intensity-Modulated 22

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × epigallocatechin gallate × 90 days × Clear all

NCT04553666 2026-05-07

ReFOCUS1

University of Rochester

Phase 2 Completed

24 enrolled 17 charts

Frailty, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡